Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KIR3DL05 and KIR3DS02 Recognition of a Nonclassical MHC Class I Molecule in the Rhesus Macaque Implicated in Pregnancy Success. | Front Immunol | 2022 | 35401580 | PubTator, text mining | PubMed |
| Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients. | Front Immunol | 2022 | 35401575 | PubTator, text mining | PubMed |
| Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components. | Front Immunol | 2022 | 35401503 | PubTator, text mining | PubMed |
| Engineering strategies to enhance oncolytic viruses in cancer immunotherapy. | Signal Transduct Target Ther | 2022 | 35387984 | PubTator, text mining | PubMed |
| Evaluation of Immune Infiltration Based on Image Plus Helps Predict the Prognosis of Stage III Gastric Cancer Patients with Significantly Different Outcomes in Northeastern China. | Dis Markers | 2022 | 35371344 | PubTator, text mining | PubMed |
| Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma. | J Cancer | 2022 | 35371331 | PubTator, text mining | PubMed |
| A Comprehensive Atlas of Immunological Differences Between Humans, Mice, and Non-Human Primates. | Front Immunol | 2022 | 35359965 | PubTator, text mining | PubMed |
| It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity. | Front Immunol | 2022 | 35359957 | PubTator, text mining | PubMed |
| Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response. | Front Immunol | 2022 | 35359945 | PubTator, text mining | PubMed |
| Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity. | Front Immunol | 2022 | 35355982 | PubTator, text mining | PubMed |
| Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication. | Blood Cancer J | 2022 | 35351868 | PubTator, text mining | PubMed |
| Cadherin-16 inhibits thyroid carcinoma cell proliferation and invasion. | Oncol Lett | 2022 | 35350592 | PubTator, text mining | PubMed |
| Evolutionary plasticity in the requirement for force exerted by ligand endocytosis to activate C. elegans Notch proteins. | Curr Biol | 2022 | 35349791 | PubTator, text mining | PubMed |
| Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse. | J Clin Invest | 2022 | 35349491 | PubTator, text mining | PubMed |
| A Brief Overview of Global Trends in MSC-Based Cell Therapy. | Stem Cell Rev Rep | 2022 | 35344199 | PubTator, text mining | PubMed |
| CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity. | Nat Commun | 2022 | 35338135 | PubTator, text mining | PubMed |
| The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells. | Diagnostics (Basel) | 2022 | 35328127 | PubTator, text mining | PubMed |
| T-cell Receptor Is a Threshold Detector: Sub- and Supra-Threshold Stochastic Resonance in TCR-MHC Clusters on the Cell Surface. | Entropy (Basel) | 2022 | 35327900 | PubTator, text mining | PubMed |
| (Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition. | Biomedicines | 2022 | 35327427 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus. | Biomedicines | 2022 | 35327364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=32